ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar mukherjeepicks (< 20) Submitted: 1/5/2013 10:50:43 PM : Outperform Start Price: $4.89 ACAD Score: +10.90

Part of my strategy SHAWBUP

Featured Broker Partners


Advertisement